Becker's Healthcare July 29, 2024
The FDA has approved Guardant Health’s Shield blood test for colon cancer screening.
The Shield blood test has been approved as a primary screening method for adults over 45 with an average risk for colon cancer, according to a July 29 news release from Guardant.
With FDA approval, the Shield blood test becomes the first colon cancer screening method that meets Medicare coverage requirements.
The blood test can be administered during a routine blood draw,...
Today's Sponsors
Today's Sponsor